Reports
Reports
Bovine blood plasma derivatives are experiencing phenomenal growth owing to their demand in industries such as pharmaceuticals, nutritional, and agriculture. Growth is positivity allied to greater use from therapeutic applications and the production of vaccines for which the derivatives concerned are assessed to possess high bioactivity and rich protein content.
Overall, key trends governing the bovine blood plasma derivatives market include improvement in the plasma processing value chain and higher demand for traceable, high-quality blood plasma products.
Bovine blood plasma derivatives are essential in pharmaceutical applications for a range of conditions; such as, they contribute to exponential growth in this market. Their nutritional applications, for example in sports nutrition and finishing touches in infant formula, similarly continue to grow given their higher nutritional value.
In addition to this, the agriculture industry works by utilizing such by-products as key formulation components in animal feed. The bovine blood plasma derivatives market is driven in the forecast period by innovations in processing and an increase in demand across multiple industries.
However, this growth is constrained by factors such as regulatory scrutiny and ethical concerns around sourcing. Overall, the outlook for this market continues to be bright, with ongoing research and development activities furthering applications and efficiency in products developed.
The growth of the bovine blood plasma derivatives market is attributed to high demand from the animal feed industry and growing demand from functional food industries. Bovine plasma protein derivatives, like spray-dried and hydrolyzed bovine plasma proteins for enhancing feed quality and animal health, are playing an important role here.
For example, spray-dried plasma proteins greatly enhance the production of milk in dairy cows without affecting the reproductive health of the cow, while hydrolyzed plasma helps in reducing post-weaning diarrhea and improving growth performance in pigs.
Animal feed industry is one of the key drivers in the growth of the bovine blood plasma derivatives market. According to the Institute for Feed Education and Research, the U.S. alone witnessed a high consumption level of the ingredient in 2019, mainly consumed by beef cattle, hogs, and broiler chicken.
This interest is supported by the fact that global feed production continues to increase, recording a 1% growth in 2020 to about 1,187.7 million metric tons, according to Alltech's Global Feed Survey, indicating increasing demand for premium feed ingredients like bovine plasma derivatives.
Furthermore, bovine blood plasma proteins are used in nutritional enhancement in food and beverages. The development regarding collection and processing of blood has enabled the inclusion of proteins in functional foods and nutritional supplements. The high digestibility and economic viability of the proteins further make them an excellent substitute for traditional ingredients in baked products, such as eggs.
With further innovations in processing technologies and an increase in demand for animal feed and nutritional supplements, the prospects of the future market look very encouraging. In contrast, this industry will also have challenges to tackle in terms of verdicts regarding regulatory standards and sourcing ethics.
Overall, the bovine blood plasma derivatives market will expand significantly with its versatile applications and the rising demand for high-quality protein sources.
| Attribute | Detail |
|---|---|
| Bovine Blood Plasma Derivatives Market Drivers |
|
The bovine blood plasma derivatives market has been developing drastically with improvements in blood collection and processing technologies. In the past, blood collection for pharmaceutical and food ingredients had a minimal level of technological intervention.
Modern applications in diagnostics, serum media, and research require high-quality blood products. This has, in turn, led to the evolution of better methods of collection to ensure product integrity and safety. The modern technology in blood collection has been adopted across the advanced countries in Europe; primarily Germany and Scandinavia.
The semi-automatic process of blood collection used by most countries today was adapted from these countries. Fully automatic and semi-automatic systems are consistent, efficient, and of higher standards in blood collection.
Various blood collection systems can be provided by different suppliers in order to satisfy the demand for customized services. For instance, Butina AB (Sweden) offers specialized equipment: RotaStick bleeding carousel, intermediate storage RectaStore, BallTec plasma, and hemoglobin dryers.
These state-of-the-art systems fasten the speed of blood collection and processing, thereby increasing production capabilities for bovine blood derivatives. Advanced technologies that speed up the collection process also improve the overall quality of blood derivatives, which is necessary for high-level procurement for use in various medical and research applications.
This leads to increased bovine blood derivative production, hence meeting the increased demand by the pharmaceutical, diagnostic, and research sectors.
The latest trend is that of the inclination of the pharmaceutical industry toward the development of advanced drug delivery system. The bovine blood plasma derivatives, majorly comprising albumin and immunoglobulins, see applications in the formulation of biopharmaceuticals and vaccines because of its unique biochemical property.
For instance, albumin is generally used as a stabilizer in drug formulations, usually added to such drugs to extend the shelf life and improve the therapeutic proteins and vaccines. This peculiar property of albumin of binding to different drugs and biologics makes it work as an excipient in the development of extended-release formulations for achievement of high level of patient compliance and betterment of therapeutic outcomes.
On the other hand, the increased demand for biologics and complex pharmaceuticals necessitating high-tech delivery mechanisms has accelerated the demand for quality plasma derivatives. These derivatives have become integral in the development of formulations providing control, targeted delivery, and protection of the active pharmaceutical ingredient (API) from degradation.
With continued innovation in areas such as Nan medicine, gene therapy, and personalized medicine within the pharmaceutical industry, demand for reliable excipients like bovine plasma derivatives will likely rise, further driving bovine blood plasma derivatives market expansion.
Moreover, the regulatory agencies' approval of bovine plasma derivatives in drug formulation has further boosted their adoption in the pharmaceutical industry. With safety profiles and claims in their functionality very well documented, they eventually turn out to be a preferred choice for drug developers when adhering to the strict quality and efficacy standards of drugs in use today.
The demand for bovine blood plasma derivatives is bound to grow with the growth of the pharmaceuticals industry across the world, especially in new markets.
By derivatives type, the thrombin segment is projected to dominate the global bovine blood plasma derivatives market during the forecast period. This dominance is attributed to its crucial role in surgical procedures and biomedical research.
Thrombin from bovine origin is a proteolytic enzyme with multifunctional activities that have typically been used as a drug for hemostasis during surgery, thereby proving to be an integral part of this field of medicine. For instance, thrombin turns the soluble plasma protein fibrinogen into fibrin, which forms the actual framework for a blood clot.
This is a critical action in controlling bleeding during surgeries, for example, liver resection, spinal procedures, and vascular surgeries like peripheral arterial bypass and dialysis access.
The high effectiveness of bovine thrombin in inducing rapid hemostasis has made it the agent of choice among surgeons worldwide. In a comparatively clinical trial, hemostasis at 10 minutes was achieved by bovine thrombin in 95% of patients. This inference underpins its efficiency in surgical settings.
Other than the surgical uses of bovine thrombin, this compound has some applications in the laboratory and research field.
According to WHO data 2023, more than 300 million surgeries are performed each year at the global level, and the number of surgical procedures performed around the world has increased dramatically over time.
As the number of surgical procedures increases, the demand for the use of bovine derivatives thrombin are also likely to increase during the forecast period. In addition, bovine thrombin can specifically cleave some proteins. Therefore, during the production of recombinant proteins, it is used in removing affinity tags from fusion proteins.
The US grade segment is projected to dominate the global bovine blood plasma derivatives market during the forecast period. The dominance of this segment is a result of the superior quality and reliability of U.S.-origin bovine plasma for a wide range of medical and research applications.
Innovative Grade U.S. Origin Bovine Plasma is sourced from United States Department of Agriculture-approved facilities in the United States, assuring high-quality plasma. This rigid process of sourcing plasma ensures that the plasma is rich in valuable proteins such as albumin, immunoglobulins, complement, lipoproteins, and coagulation proteins for use in a wide range of applications.
Consistency and reliability make U.S.-origin bovine plasma the preferred choice for both: clinical and research settings. In coagulation assays, for example, the accurate measurement of the various blood factors that form clots is paramount to diagnosis and the management of bleeding disorders.
Plasma of high quality is necessary for accurate and reproducible results, which are important in terms of patient safety and effective treatment.
Besides, the pledge of quality in U.S.-origin bovine plasma products turns into dependable outcomes across a variety of applications-from diagnostics to biopharmaceutical production. Similarly, this reliability could explain the reason why U.S. grade bovine derivatives are dominant in the market, as it becomes an important attribute in the decision-making process of the stakeholders.
As various global markets give increasing priority to quality and consistency, the U.S.-origin bovine derivatives are in a position to lead bovine blood plasma derivatives market demand for a reliable source of high-quality plasma for a variety of medical and research applications. That trend signals how serious sourcing standards or production are in giving way to market leadership.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America’s bovine blood plasma derivatives market is poised for significant growth due to several driving factors. The dominance of the region is driven by several key factors that enhance its market attractiveness. First, well-developed healthcare infrastructure with a considerable volume of surgical procedures insatiably contributes to generating demand for bovine blood plasma derivatives.
For instance, intraoperative bleeding is treated or prevented with bovine thrombin usage. According to the National Center for Health Statistics, approximately 1.2 million cholecystectomies are performed every year in the U.S, and the cesarean deliveries as a percentage of births was recorded at 32.1% in the year 2022.
Hence, this high frequency of surgeries doubles and triples the demand for hemostatic agents such as bovine thrombin, thereby driving the bovine blood plasma derivatives market growth. Worth mentioning here is that the growth of the North American Animal Nutrition Industry is also aiding the market expansion.
Contributions the American Feed Industry Association made to the U.S. economy totaled more than $267 billion in 2022. Its counterpart, the 2022 Global Feed Survey and Agri-Food Outlook from Alltech, estimated the North American production volume for 2021 pet food at 10.6 million metric tons. This represented an increase of 12.7% over the prior year and the highest growth of any feed sector.
Bovine blood plasma derivatives have an increasing use in the formulation of added health benefit pet food, since the trend is toward humanizing pets and demanding premium quality of pet foods.
Another evidence of the demand for quality pet food can be seen in Canada: more than 0.80 million tons were produced in 2021, and in mid-2022, there was a raise of 19.6% in the import of U.S. pet food. This is the continuing trend in increasing adoption of premium pet food that further fuels demand for bovine blood plasma derivatives.
The leading players in the medical simulation market include ANZCO Foods (Itoham Yonekyu Holdings), Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare), Moregate Biotech (ANZCO Foods), Proliant Health & Biologicals, LAMPIRE Biological Lab Inc., Rocky Mountain Biologicals, Thermo Fisher Scientific, Inc., Sigma-Aldrich (Merck KGaA), Kraeber & Co GmbH, and Lake Immunogenics
Each of these players have been have been profiled in the bovine blood plasma derivatives market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 2.0 Bn |
| Forecast Value in 2034 | More than US$ 3.7 Bn |
| CAGR | 5.8% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2018-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global bovine blood plasma derivatives market was valued at US$ 2.0 Bn in 2023
The bovine blood plasma derivatives business is projected to reach more than US$ 3.7 Bn by the end of 2034
Advances in technology for blood collection and processing and increasing demand for advanced drug delivery systems
The CAGR is anticipated to be 5.8% from 2024 to 2034
North America is expected to account for the largest share from 2024 to 2034
ANZCO Foods (Itoham Yonekyu Holdings), Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare), Moregate Biotech (ANZCO Foods), Proliant Health & Biologicals, LAMPIRE Biological Laboratories, Inc., Rocky Mountain Biologicals, Thermo Fisher Scientific, Inc., Sigma-Aldrich (Merck KGaA), Kraeber & Co GmbH, and Lake Immunogenics
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bovine Blood Plasma Derivatives Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, 2020-2034
4.4.1. Market Revenue Projections (US$ Bn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Value Chain Analysis
5.1.1. Prominent Companies in Bovine Blood Plasma Derivatives Value Chain
5.1.2. List of Key End-user
5.2. Porters Five Forces of Analysis
5.3. Price trend of raw material bovine plasma from 2010-2030
5.4. Global Bovine Blood Plasma Derivatives: Demand and Supply Scenario
5.5. Regulatory Scenarios
5.6. Key Industry Events
5.7. Technology Overview
5.7.1. Overview of Bovine Blood Plasma Derivatives Process
5.7.1.1. Bovine Serum Albumin (BSA)
5.7.1.2. Immunoglobulin
5.7.1.3. Fetal Bovine Serum (FBS)
5.7.1.4. Technology -Summary of blood collection and processing methods
5.7.2. Overview of Bovine Blood Plasma Yield
5.8. Distributors Landscape
5.9. Major Brand Analysis
5.10. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Kits and Reagents
6.3.2. Instruments
6.3.3. Software and Service
6.4. Market Attractiveness Analysis, by Product
7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2034
7.3.1. Molecular Diagnostics
7.3.2. Hematology
7.3.3. Immunodiagnostics
7.3.4. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Derivative Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Derivative Type, 2020-2034
8.3.1. Immunoglobulin
8.3.2. Fibrinogen
8.3.3. Serum Albumin
8.3.4. Fetal Bovine Serum
8.3.5. Thrombin
8.3.6. Transferrin
8.3.7. Others
8.4. Market Attractiveness Analysis, by Derivative Type
9. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Source
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Source, 2020-2034
9.3.1. US Grade
9.3.2. Australia Grade
9.3.3. New Zealand Grade
9.3.4. Others
9.4. Market Attractiveness Analysis, by Source
10. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2020-2034
10.3.1. Veterinary Industry
10.3.1.1. Veterinary Hospitals
10.3.1.2. Veterinary Reference Laboratories
10.3.1.3. POC/In House Testing
10.3.1.4. Veterinary Research laboratories
10.3.2. Food Industry
10.3.3. Academic and Research Institutes
10.3.4. Cell Culture/ Biotechnology
10.3.5. Cosmetic Industry
10.3.6. Pharmaceutical Industry
10.3.7. Diagnostics Industry
10.3.8. Others
10.4. Market Attractiveness Analysis, by End-user
11. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2020-2034
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Bovine Blood Plasma Derivatives Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2020-2034
12.2.1. Kits and Reagents
12.2.2. Instruments
12.2.3. Software and Service
12.3. Market Value Forecast, by Technology, 2020-2034
12.3.1. Molecular Diagnostics
12.3.2. Hematology
12.3.3. Immunodiagnostics
12.3.4. Others
12.4. Market Value Forecast, by Derivative Type, 2020-2034
12.4.1. Immunoglobulin
12.4.2. Fibrinogen
12.4.3. Serum Albumin
12.4.4. Fetal Bovine Serum
12.4.5. Thrombin
12.4.6. Transferrin
12.4.7. Others
12.5. Market Value Forecast, by Source, 2020-2034
12.5.1. US Grade
12.5.2. Australia Grade
12.5.3. New Zealand Grade
12.5.4. Others
12.6. Market Value Forecast, by End-user, 2020-2034
12.6.1. Veterinary Industry
12.6.1.1. Veterinary Hospitals
12.6.1.2. Veterinary Reference Laboratories
12.6.1.3. POC/In House Testing
12.6.1.4. Veterinary Research laboratories
12.6.2. Food Industry
12.6.3. Academic and Research Institutes
12.6.4. Cell Culture/ Biotechnology
12.6.5. Cosmetic Industry
12.6.6. Pharmaceutical Industry
12.6.7. Diagnostics Industry
12.6.8. Others
12.7. Market Value Forecast, by Country, 2020-2034
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Technology
12.8.3. By Derivative Type
12.8.4. By Source
12.8.5. By End-user
12.8.6. By Country
13. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2020-2034
13.2.1. Kits and Reagents
13.2.2. Instruments
13.2.3. Software and Service
13.3. Market Value Forecast, by Technology, 2020-2034
13.3.1. Molecular Diagnostics
13.3.2. Hematology
13.3.3. Immunodiagnostics
13.3.4. Others
13.4. Market Value Forecast, by Derivative Type, 2020-2034
13.4.1. Immunoglobulin
13.4.2. Fibrinogen
13.4.3. Serum Albumin
13.4.4. Fetal Bovine Serum
13.4.5. Thrombin
13.4.6. Transferrin
13.4.7. Others
13.5. Market Value Forecast, by Source, 2020-2034
13.5.1. US Grade
13.5.2. Australia Grade
13.5.3. New Zealand Grade
13.5.4. Others
13.6. Market Value Forecast, by End-user, 2020-2034
13.6.1. Veterinary Industry
13.6.1.1. Veterinary Hospitals
13.6.1.2. Veterinary Reference Laboratories
13.6.1.3. POC/In House Testing
13.6.1.4. Veterinary Research laboratories
13.6.2. Food Industry
13.6.3. Academic and Research Institutes
13.6.4. Cell Culture/ Biotechnology
13.6.5. Cosmetic Industry
13.6.6. Pharmaceutical Industry
13.6.7. Diagnostics Industry
13.6.8. Others
13.7. Market Value Forecast, by Country/Sub-region, 2020-2034
13.7.1. Germany
13.7.2. UK
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Technology
13.8.3. By Derivative Type
13.8.4. By Source
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2020-2034
14.2.1. Kits and Reagents
14.2.2. Instruments
14.2.3. Software and Service
14.3. Market Value Forecast, by Technology, 2020-2034
14.3.1. Molecular Diagnostics
14.3.2. Hematology
14.3.3. Immunodiagnostics
14.3.4. Others
14.4. Market Value Forecast, by Derivative Type, 2020-2034
14.4.1. Immunoglobulin
14.4.2. Fibrinogen
14.4.3. Serum Albumin
14.4.4. Fetal Bovine Serum
14.4.5. Thrombin
14.4.6. Transferrin
14.4.7. Others
14.5. Market Value Forecast, by Source, 2020-2034
14.5.1. US Grade
14.5.2. Australia Grade
14.5.3. New Zealand Grade
14.5.4. Others
14.6. Market Value Forecast, by End-user, 2020-2034
14.6.1. Veterinary Industry
14.6.1.1. Veterinary Hospitals
14.6.1.2. Veterinary Reference Laboratories
14.6.1.3. POC/In House Testing
14.6.1.4. Veterinary Research laboratories
14.6.2. Food Industry
14.6.3. Academic and Research Institutes
14.6.4. Cell Culture/ Biotechnology
14.6.5. Cosmetic Industry
14.6.6. Pharmaceutical Industry
14.6.7. Diagnostics Industry
14.6.8. Others
14.7. Market Value Forecast, by Country/Sub-region, 2020-2034
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Product
14.8.2. By Technology
14.8.3. By Derivative Type
14.8.4. By Source
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Bovine Blood Plasma Derivatives Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2020-2034
15.2.1. Kits and Reagents
15.2.2. Instruments
15.2.3. Software and Service
15.3. Market Value Forecast, by Technology, 2020-2034
15.3.1. Molecular Diagnostics
15.3.2. Hematology
15.3.3. Immunodiagnostics
15.3.4. Others
15.4. Market Value Forecast, by Derivative Type, 2020-2034
15.4.1. Immunoglobulin
15.4.2. Fibrinogen
15.4.3. Serum Albumin
15.4.4. Fetal Bovine Serum
15.4.5. Thrombin
15.4.6. Transferrin
15.4.7. Others
15.5. Market Value Forecast, by Source, 2020-2034
15.5.1. US Grade
15.5.2. Australia Grade
15.5.3. New Zealand Grade
15.5.4. Others
15.6. Market Value Forecast, by End-user, 2020-2034
15.6.1. Veterinary Industry
15.6.1.1. Veterinary Hospitals
15.6.1.2. Veterinary Reference Laboratories
15.6.1.3. POC/In House Testing
15.6.1.4. Veterinary Research laboratories
15.6.2. Food Industry
15.6.3. Academic and Research Institutes
15.6.4. Cell Culture/ Biotechnology
15.6.5. Cosmetic Industry
15.6.6. Pharmaceutical Industry
15.6.7. Diagnostics Industry
15.6.8. Others
15.7. Market Value Forecast, by Country/Sub-region, 2020-2034
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Product
15.8.2. By Technology
15.8.3. By Derivative Type
15.8.4. By Source
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Bovine Blood Plasma Derivatives Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product, 2020-2034
16.2.1. Kits and Reagents
16.2.2. Instruments
16.2.3. Software and Service
16.3. Market Value Forecast, by Technology, 2020-2034
16.3.1. Molecular Diagnostics
16.3.2. Hematology
16.3.3. Immunodiagnostics
16.3.4. Others
16.4. Market Value Forecast, by Derivative Type, 2020-2034
16.4.1. Immunoglobulin
16.4.2. Fibrinogen
16.4.3. Serum Albumin
16.4.4. Fetal Bovine Serum
16.4.5. Thrombin
16.4.6. Transferrin
16.4.7. Others
16.5. Market Value Forecast, by Source, 2020-2034
16.5.1. US Grade
16.5.2. Australia Grade
16.5.3. New Zealand Grade
16.5.4. Others
16.6. Market Value Forecast, by End-user, 2020-2034
16.6.1. Veterinary Industry
16.6.1.1. Veterinary Hospitals
16.6.1.2. Veterinary Reference Laboratories
16.6.1.3. POC/In House Testing
16.6.1.4. Veterinary Research laboratories
16.6.2. Food Industry
16.6.3. Academic and Research Institutes
16.6.4. Cell Culture/ Biotechnology
16.6.5. Cosmetic Industry
16.6.6. Pharmaceutical Industry
16.6.7. Diagnostics Industry
16.6.8. Others
16.7. Market Value Forecast, by Country/Sub-region, 2020-2034
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Product
16.8.2. By Technology
16.8.3. By Derivative Type
16.8.4. By Source
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis, by Company (2023)
17.3. Company Profiles
17.3.1. ANZCO Foods (Itoham Yonekyu Holdings)
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategies
17.3.1.5. Recent Developments
17.3.2. Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare)
17.3.2.1. Company Overview
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. Business Strategies
17.3.2.5. Recent Developments
17.3.3. Moregate Biotech (ANZCO Foods)
17.3.3.1. Company Overview
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. Business Strategies
17.3.3.5. Recent Developments
17.3.4. Proliant Health & Biologicals
17.3.4.1. Company Overview
17.3.4.2. Financial Overview
17.3.4.3. Product Portfolio
17.3.4.4. Business Strategies
17.3.4.5. Recent Developments
17.3.5. LAMPIRE Biological Laboratories, Inc.
17.3.5.1. Company Overview
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. Business Strategies
17.3.5.5. Recent Developments
17.3.6. Rocky Mountain Biologicals, LLC
17.3.6.1. Company Overview
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. Business Strategies
17.3.6.5. Recent Developments
17.3.7. Thermo Fisher Scientific Inc.
17.3.7.1. Company Overview
17.3.7.2. Financial Overview
17.3.7.3. Product Portfolio
17.3.7.4. Business Strategies
17.3.7.5. Recent Developments
17.3.8. Sigma-Aldrich (Merck KGaA)
17.3.8.1. Company Overview
17.3.8.2. Financial Overview
17.3.8.3. Product Portfolio
17.3.8.4. Business Strategies
17.3.8.5. Recent Developments
17.3.9. Kraeber & Co GmbH
17.3.9.1. Company Overview
17.3.9.2. Financial Overview
17.3.9.3. Product Portfolio
17.3.9.4. Business Strategies
17.3.9.5. Recent Developments
17.3.10. Auckland BioSciences
17.3.10.1. Company Overview
17.3.10.2. Financial Overview
17.3.10.3. Product Portfolio
17.3.10.4. Business Strategies
17.3.10.5. Recent Developments
17.3.11. Lake Immunogenics
17.3.11.1. Company Overview
17.3.11.2. Financial Overview
17.3.11.3. Product Portfolio
17.3.11.4. Business Strategies
17.3.11.5. Recent Developments
List of Tables
Table 01: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 02: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034
Table 03: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034
Table 04: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034
Table 05: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034
Table 06: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034
Table 07: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Region, 2020-2034
Table 08: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country, 2020-2034
Table 09: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 10: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034
Table 11: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034
Table 12: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034
Table 13: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034
Table 14: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034
Table 15: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 16: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 17: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034
Table 18: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034
Table 19: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034
Table 20: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034
Table 21: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034
Table 22: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 23: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 24: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034
Table 25: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034
Table 26: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034
Table 27: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034
Table 28: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034
Table 29: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 30: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 31: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034
Table 32: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034
Table 33: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034
Table 34: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034
Table 35: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034
Table 36: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 37: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 38: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034
Table 39: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034
Table 40: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034
Table 41: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034
Table 42: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034
List of Figures
Figure 01: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, 2020-2034
Figure 02: Global Bovine Blood Plasma Derivatives Market Value Share, by Product, 2023
Figure 03: Global Bovine Blood Plasma Derivatives Market Value Share, by Technology, 2023
Figure 04: Global Bovine Blood Plasma Derivatives Market Value Share, by Derivatives Type, 2023
Figure 05: Global Bovine Blood Plasma Derivatives Market Value Share, by Source, 2023
Figure 06: Global Bovine Blood Plasma Derivatives Market Value Share, by End-use Industry, 2023
Figure 07: Global Bovine Blood Plasma Derivatives Market Value Share, by Region, 2023
Figure 08: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 09: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Product, 2023
Figure 10: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Product, 2034
Figure 11: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034
Figure 12: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Kits and Reagents, 2020‒2034
Figure 13: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Kits and Reagents, 2023 and 2034
Figure 14: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Instruments, 2020‒2034
Figure 15: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Instruments, 2023 and 2034
Figure 16: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Software and Service, 2020‒2034
Figure 17: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Software and Service, 2023 and 2034
Figure 18: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034
Figure 19: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Technology, 2023
Figure 20: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Technology, 2034
Figure 21: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034
Figure 22: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Molecular Diagnostics, 2020‒2034
Figure 23: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Molecular Diagnostics, 2023 and 2034
Figure 24: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Hematology, 2020‒2034
Figure 25: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Hematology, 2023 and 2034
Figure 26: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Immunodiagnostics, 2020‒2034
Figure 27: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Immunodiagnostics, 2023 and 2034
Figure 28: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Others, 2020‒2034
Figure 29: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Others, 2023 and 2034
Figure 30: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034
Figure 31: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Derivatives Type, 2023
Figure 32: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Derivatives Type, 2034
Figure 33: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034
Figure 34: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Immunoglobulin, 2020‒2034
Figure 35: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Immunoglobulin, 2023 and 2034
Figure 36: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Fibrinogen, 2020‒2034
Figure 37: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Fibrinogen, 2023 and 2034
Figure 38: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Serum Albumin, 2020‒2034
Figure 39: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Serum Albumin, 2023 and 2034
Figure 40: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Fetal Bovine Serum, 2020‒2034
Figure 41: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Fetal Bovine Serum, 2023 and 2034
Figure 42: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Thrombin, 2020‒2034
Figure 43: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Thrombin, 2023 and 2034
Figure 44: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Transferrin, 2020‒2034
Figure 45: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Transferrin, 2023 and 2034
Figure 46: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Others, 2020‒2034
Figure 47: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Others, 2023 and 2034
Figure 48: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034
Figure 49: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Source, 2023
Figure 50: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Source, 2034
Figure 51: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034
Figure 52: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by US Grade, 2020‒2034
Figure 53: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by US Grade, 2023 and 2034
Figure 54: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Australia Grade, 2020‒2034
Figure 55: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Australia Grade, 2023 and 2034
Figure 56: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by New Zealand Grade, 2020‒2034
Figure 57: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by New Zealand Grade, 2023 and 2034
Figure 58: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Others, 2020‒2034
Figure 59: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Others, 2023 and 2034
Figure 60: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034
Figure 61: Global Bovine Blood Plasma Derivatives Market Share Analysis, by End-use Industry, 2023
Figure 62: Global Bovine Blood Plasma Derivatives Market Share Analysis, by End-use Industry, 2034
Figure 63: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034
Figure 64: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Veterinary Industry, 2020‒2034
Figure 65: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Veterinary Industry, 2023 and 2034
Figure 66: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Food Industry, 2020‒2034
Figure 67: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Food Industry, 2023 and 2034
Figure 68: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Academic and Research Institutes, 2020‒2034
Figure 69: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Academic and Research Institutes, 2023 and 2034
Figure 70: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Cell Culture/ Biotechnology, 2020‒2034
Figure 71: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Cell Culture/ Biotechnology, 2023 and 2034
Figure 72: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Cosmetic Industry, 2020‒2034
Figure 73: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Cosmetic Industry, 2023 and 2034
Figure 74: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Pharmaceutical Industry, 2020‒2034
Figure 75: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Pharmaceutical Industry, 2023 and 2034
Figure 76: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Diagnostics Industry, 2020‒2034
Figure 77: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Diagnostics Industry, 2023 and 2034
Figure 78: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Others, 2020‒2034
Figure 79: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Others, 2023 and 2034
Figure 80: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Region, 2023 and 2034
Figure 81: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Region, 2023
Figure 82: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Region, 2034
Figure 83: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Region, 2023-2034
Figure 84: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 85: North America Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country, 2023 and 2034
Figure 86: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country, 2024-2034
Figure 87: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 88: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034
Figure 89: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034
Figure 90: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034
Figure 91: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034
Figure 92: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034
Figure 93: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034
Figure 94: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034
Figure 95: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034
Figure 96: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034
Figure 97: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 98: Europe Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 99: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 100: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 101: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034
Figure 102: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034
Figure 103: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034
Figure 104: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034
Figure 105: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034
Figure 106: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034
Figure 107: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034
Figure 108: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034
Figure 109: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034
Figure 110: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 111: Asia Pacific Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 112: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 113: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 114: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034
Figure 115: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034
Figure 116: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034
Figure 117: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034
Figure 118: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034
Figure 119: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034
Figure 120: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034
Figure 121: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034
Figure 122: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034
Figure 123: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 124: Latin America Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 125: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 126: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 127: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034
Figure 128: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034
Figure 129: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034
Figure 130: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034
Figure 131: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034
Figure 132: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034
Figure 133: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034
Figure 134: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034
Figure 135: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034
Figure 136: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 137: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 138: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 139: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 140: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034
Figure 141: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034
Figure 142: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034
Figure 143: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034
Figure 144: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034
Figure 145: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034
Figure 146: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034
Figure 147: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034
Figure 148: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bovine Blood Plasma Derivatives Market